Showing results (41-50 of 73) with videos related to
Sort By:
Pageof 8
Advances in Therapy|September 7, 2017
Once-Daily Triple Therapy in Patients with Advanced COPD: Healthcare Resource Utilization Data and Associated Costs from the FULFIL TrialAfisi S Ismaila, Ruby Birk, Dhvani Shah, et al.Canadian Journal of Public Health = Revue Canadienne De Sante Publique|May 7, 2008
Patient views on reminder letters for influenza vaccinations in an older primary care patient population: a mixed methods studyKelly K Anderson, Rolf J Sebaldt, Lynne Lohfeld, et al.International Journal of Chronic Obstructive Pulmonary Disease|April 22, 2024
Characteristics of Users and New Initiators of Single- and Multiple-Inhaler Triple Therapy for Chronic Obstructive Pulmonary Disease in GermanyKai-Michael Beeh, Kieran J Rothnie, Jing Claussen, et al.International Journal of Chronic Obstructive Pulmonary Disease|April 8, 2020
Evaluating Patient Preferences of Maintenance Therapy for the Treatment of Chronic Obstructive Pulmonary Disease: A Discrete Choice Experiment in the UK, USA and GermanyHannah B Lewis, Melanie Schroeder, Necdet B Gunsoy, et al.ERJ Open Research|November 14, 2019
Clinical effectiveness of once-daily fluticasone furoate/umeclidinium/vilanterol in usual practice: the COPD INTREPID study designSally Worsley, Neil Snowise, David M G Halpin, et al.Pulmonary Therapy|February 11, 2026
A Pragmatic RCT of FF/UMEC/VI in Patients with Uncontrolled Asthma: PERFORM ProtocolStephen G Noorduyn, Nicola Brown, Jodie Crawford, et al.Respiratory Research|December 21, 2024
Assessing the comparative effects of interventions in COPD: a tutorial on network meta-analysis for cliniciansKatrin Haeussler, Afisi S Ismaila, Mia Malmenäs, et al.International Journal of Chronic Obstructive Pulmonary Disease|March 14, 2022
Benefit of Prompt versus Delayed Use of Single-Inhaler Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Following a COPD ExacerbationDavid Mannino, Michael Bogart, Guillaume Germain, et al.International Journal of Chronic Obstructive Pulmonary Disease|September 14, 2022
Clinical and Economic Impact of Long-Term Inhaled Corticosteroid Withdrawal in Patients with Chronic Obstructive Pulmonary Disease Treated with Triple Therapy in SpainVictoria Neches García, Laura Amanda Vallejo-Aparicio, Afisi S Ismaila, et al.Clinical Biochemistry|October 9, 2007
Evidence for the use of B-type natriuretic peptides for screening asymptomatic populations and for diagnosis in primary careStephen A Hill, Cynthia M Balion, Pasqualina Santaguida, et al.Pageof 8